Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (FY)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 22.75%5.1B | 17.08%4.15B | 22.69%1.17B | 17.16%1.06B | 969.24M | 961.04M | 16.66%3.55B | 950.75M | 902.95M | 22.79%3.04B |
| Cost of revenue | 24.31%4.33B | 17.88%3.48B | 23.55%986.03M | 17.92%886.76M | 810.33M | 798.49M | 15.53%2.95B | 798.05M | 751.99M | 19.23%2.56B |
| Gross profit | 14.67%771.7M | 13.10%672.99M | 18.15%180.42M | 13.35%171.11M | 158.91M | 162.54M | 22.67%595.04M | 152.7M | 150.96M | 45.74%485.1M |
| Operating expense | 30.67%679.83M | 12.20%520.26M | 8.80%127.4M | 9.76%132.76M | 127.56M | 132.54M | 11.46%463.7M | 117.09M | 120.95M | 0.61%416.04M |
| Operating profit | -39.85%91.87M | 16.28%152.73M | 48.91%53.03M | 27.80%38.36M | 31.35M | 30M | 90.20%131.34M | 35.61M | 30.01M | 185.60%69.06M |
| Net non-operating interest income (expenses) | -29.48%-4.16M | 5.31%-3.21M | 3.38%-773K | 33.17%-681K | -707K | -1.05M | 36.00%-3.39M | -800K | -1.02M | -18.65%-5.3M |
| Non-operating interest income | 6,471.43%460K | 40.00%7K | 33.33%4K | --0 | ---- | ---- | 66.67%5K | --3K | --0 | -25.00%3K |
| Non-operating interest expense | 43.49%4.62M | -5.24%3.22M | -3.24%777K | -33.17%681K | --710K | --1.05M | -35.94%3.4M | --803K | --1.02M | 18.61%5.3M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -413K | |||||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --413K |
| Other non-operating income (expenses) | -153.03%-718K | 110.52%1.35M | 71.36%-179K | 100.64%75K | 1.54M | -85K | -459.46%-12.88M | -625K | -11.74M | 90.94%3.58M |
| Income before tax | -42.34%86.99M | 31.11%150.87M | 52.33%52.07M | 118.84%37.75M | 32.19M | 28.86M | 71.94%115.07M | 34.18M | 17.25M | 180.37%66.93M |
| Income tax | -39.30%24.53M | 8.08%40.41M | 40.70%10.07M | 100.55%12.68M | 8.25M | 9.41M | 2,657.15%37.39M | 7.16M | 6.32M | 189.98%1.36M |
| Net income | -43.46%62.46M | 42.19%110.46M | 55.40%42M | 129.45%25.07M | 23.94M | 19.46M | 18.48%77.69M | 27.03M | 10.93M | 180.20%65.57M |
| Net income continuous operations | -43.46%62.46M | 42.19%110.46M | 55.41%42M | 129.42%25.07M | --23.94M | --19.46M | 18.48%77.69M | --27.02M | --10.93M | 180.20%65.57M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -43.46%62.46M | 42.19%110.46M | 55.40%42M | 129.45%25.07M | 23.94M | 19.46M | 18.48%77.69M | 27.03M | 10.93M | 180.20%65.57M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -43.46%62.46M | 42.19%110.46M | 55.40%42M | 129.45%25.07M | 23.94M | 19.46M | 18.48%77.69M | 27.03M | 10.93M | 180.20%65.57M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -43.66%22.14 | 24.47%39.3 | 46.03%14.895 | 94.33%8.875 | 8.515 | 7.015 | 11.58%31.575 | 10.2 | 4.567 | 191.85%28.2973 |
| Diluted earnings per share | -42.91%21.42 | 27.53%37.52 | 52.59%14.29 | 106.94%8.52 | 8.125 | 6.585 | 3.97%29.42 | 9.365 | 4.1172 | 191.85%28.2973 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |